Levodopa is the gold standard treatment for PD symptoms, but progression due to alpha-synuclein accumulation, pathological oxidative stress, brain inflammation, and the loss of DA neurons are not abated by levodopa. This evidence concerns the gene SNCA and Parkinson disease.